Abstract
This review examines the current state of pharmaceutical care for the population in conditions of coronavirus infection (COVID-19). The authors analyze the history of the pandemic, the basic principles of the concept of pharmaceutical care, Russian and foreign experience in providing pharmaceutical care to the population during the pandemic. However, the problem of developing organizational and economic approaches to research the availability and quality of pharmaceutical care to the population with acute respiratory viral infections in conditions of COVID-19 at the regional level requires further study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
